Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Glioblastoma 9Lung Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Gliosarcoma 7Central Nervous System Neoplasms 7Prostatic Neoplasms 5Lymphoma 5Breast Neoplasms 5Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia 4Kidney Neoplasms 4Pancreatic Neoplasms 3Neoplasm Metastasis 3Lymphoma, Non-Hodgkin 3Head and Neck Neoplasms 3Brain Neoplasms 3Urogenital Neoplasms 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Neoplasms, Plasma Cell 2Neoplasms 2Multiple Myeloma 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Carcinoma, Squamous Cell 2Carcinoma, Renal Cell 2Carcinoma, Large Cell 2Adenocarcinoma of Lung 2

Interventions

Cisplatin 2motexafin gadolinium 1Standard of Care 1Radiotherapy 1Radiation 1Practice Guidelines as Topic 1Erlotinib Hydrochloride 1Docetaxel 1Chemoradiotherapy 1Blood Specimen Collection 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Tonsillar Neoplasms × motexafin gadolinium × Clear all
NCT00080028 2007-05-08

Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer

Pharmacyclics LLC.

Phase 1 Terminated
18 enrolled
Head & Neck

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Oropharyngeal Neoplasms, Tonsillar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡